[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1064671A1 - Process for making amlodipine maleate, the amlodipine maleate prepared, the pharmaceutical composition and the use thereof - Google Patents

Process for making amlodipine maleate, the amlodipine maleate prepared, the pharmaceutical composition and the use thereof

Info

Publication number
HK1064671A1
HK1064671A1 HK04107618A HK04107618A HK1064671A1 HK 1064671 A1 HK1064671 A1 HK 1064671A1 HK 04107618 A HK04107618 A HK 04107618A HK 04107618 A HK04107618 A HK 04107618A HK 1064671 A1 HK1064671 A1 HK 1064671A1
Authority
HK
Hong Kong
Prior art keywords
amlodipine maleate
pharmaceutical composition
making
prepared
amlodipine
Prior art date
Application number
HK04107618A
Other languages
English (en)
Inventor
Frantisek Picha
Pavel Slanina
Franciscus Bernardus Benneker
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29740325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1064671(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of HK1064671A1 publication Critical patent/HK1064671A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK04107618A 2000-12-29 2004-10-05 Process for making amlodipine maleate, the amlodipine maleate prepared, the pharmaceutical composition and the use thereof HK1064671A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25861200P 2000-12-29 2000-12-29
US80934301A 2001-03-16 2001-03-16
PCT/NL2001/000607 WO2002053542A1 (en) 2000-12-29 2001-08-15 Process for making amlodipine maleate
BE2001/0709A BE1014452A6 (nl) 2000-12-29 2001-11-05 Werkwijze voor het maken van amlodipinemaleaat.

Publications (1)

Publication Number Publication Date
HK1064671A1 true HK1064671A1 (en) 2005-02-04

Family

ID=29740325

Family Applications (2)

Application Number Title Priority Date Filing Date
HK03108272A HK1055965A1 (en) 2000-12-29 2003-11-13 Process for making amlodipine maleate.
HK04107618A HK1064671A1 (en) 2000-12-29 2004-10-05 Process for making amlodipine maleate, the amlodipine maleate prepared, the pharmaceutical composition and the use thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK03108272A HK1055965A1 (en) 2000-12-29 2003-11-13 Process for making amlodipine maleate.

Country Status (25)

Country Link
US (2) US6600047B2 (xx)
EP (1) EP1309555B1 (xx)
CN (1) CN1272319C (xx)
AP (1) AP2003002820A0 (xx)
AT (3) ATE300520T1 (xx)
BE (1) BE1014452A6 (xx)
BR (1) BR0116557A (xx)
CA (1) CA2433288C (xx)
DE (2) DE60112305T2 (xx)
DK (3) DK1309555T3 (xx)
ES (1) ES2243553T3 (xx)
FI (1) FI6788U1 (xx)
HK (2) HK1055965A1 (xx)
HR (1) HRP20030526A2 (xx)
IL (1) IL156692A0 (xx)
IS (1) IS6834A (xx)
MA (1) MA25984A1 (xx)
MX (1) MXPA03005885A (xx)
NO (1) NO20032518L (xx)
NZ (1) NZ526506A (xx)
PL (1) PL362660A1 (xx)
PT (1) PT1309555E (xx)
RS (1) RS53403A (xx)
SI (1) SI1309555T1 (xx)
WO (1) WO2002053542A1 (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
CA2433193C (en) * 2000-12-29 2006-01-31 Pfizer Limited Amide derivative of amlodipine
EP1309558A1 (en) * 2000-12-29 2003-05-14 Synthon Licensing, Ltd. Aspartate derivative of amlodipine as calcium channel antagonist
MXPA03005882A (es) * 2000-12-29 2005-04-19 Pfizer Ltd Derivado amida de amlodipina.
CA2433288C (en) 2000-12-29 2006-06-13 Pfizer Limited Process for making amlodipine maleate
US20030027848A1 (en) * 2001-06-15 2003-02-06 Anne Billotte Stabilized formulations
GB0114709D0 (en) * 2001-06-15 2001-08-08 Pfizer Ltd Stabilised formulations of amlodipine maleate
US20030180354A1 (en) * 2001-10-17 2003-09-25 Dr. Reddy's Laboratories Limited Amlodipine maleate formulations
KR100538641B1 (ko) * 2002-07-30 2005-12-22 씨제이 주식회사 암로디핀의 유기산염
KR100496436B1 (ko) 2002-07-30 2005-06-20 씨제이 주식회사 암로디핀의 유기산염
KR100467669B1 (ko) 2002-08-21 2005-01-24 씨제이 주식회사 암로디핀의 유기산염
AU2003253460A1 (en) * 2002-09-19 2004-04-08 Cj Corporation Crystalline organic acid salt of amlodipine
EP1407773A1 (en) * 2002-10-08 2004-04-14 Council of Scientific and Industrial Research A process for the preparation of s (-) amlodipine salts
US20040072879A1 (en) * 2002-10-10 2004-04-15 Dr. Reddy's Laboratories Limited Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine)
AU2002368531A1 (en) * 2002-12-30 2004-07-22 Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. Isolation of dihydropyridine derivative and preparation salts thereof
WO2005023769A1 (en) * 2003-09-04 2005-03-17 Cipla Limited Process for the preparation of amlodipine salts
KR20060086432A (ko) * 2003-11-20 2006-07-31 카운슬 오브 사이언티픽 앤드 인더스트리얼 리서치 키랄 암로디핀 염의 제조방법
WO2005089353A2 (en) * 2004-03-16 2005-09-29 Sepracor Inc. (s)-amlodipine malate
PT2077995E (pt) * 2006-11-02 2012-05-10 Millennium Pharm Inc Métodos de sintetizar sais farmacêuticos de um inibidor de fator xa
KR100843400B1 (ko) * 2006-11-14 2008-07-04 씨제이제일제당 (주) 결정성 ｓ-(-)-암로디핀 말레익산 염 무수물 및 이의제조방법
US20090062352A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched amlodipine
CN102344409B (zh) * 2011-07-20 2013-04-03 海南锦瑞制药股份有限公司 一种氨氯地平晶体、其与贝那普利药用组合物及制备方法
CN102382041B (zh) * 2011-12-02 2016-01-20 东北制药集团股份有限公司 一种马来酸氨氯地平的制备方法
CN103044314A (zh) * 2013-01-06 2013-04-17 先声药业有限公司 马来酸氨氯地平的制备方法
CN104529877A (zh) * 2015-01-22 2015-04-22 华东理工常熟研究院有限公司 氨氯地平-癸酸离子液体及其制备方法和用途
ES2886067T3 (es) 2016-10-07 2021-12-16 Silvergate Pharmaceuticals Inc Formulaciones de amlodipina
CN108358833A (zh) * 2018-03-15 2018-08-03 上海峰林生物科技有限公司 一种马来酸氨氯地平的合成工艺
US10799453B2 (en) 2018-04-11 2020-10-13 Silvergate Pharmaceuticals, Inc. Amlodipine formulations
CN109651236A (zh) * 2019-01-24 2019-04-19 浙江尖峰药业有限公司 门冬氨酸氨氯地平的晶型及其制备和应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294969A (en) * 1979-01-29 1981-10-13 Merck & Co., Inc. Process for producing 2-bromo-3,5-disubstituted pyridines
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GR851819B (xx) * 1984-08-17 1985-11-26 Wyeth John & Brother Ltd
IT1201454B (it) * 1985-08-19 1989-02-02 Boehringer Biochemia Srl 1,4-diidropiridine-2-sostituite
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
FR2602231B1 (fr) * 1986-08-04 1988-10-28 Adir Nouveaux derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US4983740A (en) 1986-08-04 1991-01-08 Adir Et Compagnie Process for 1,4-dihydropyridine compounds
GB8710493D0 (en) 1987-05-02 1987-06-03 Pfizer Ltd Dihydropyridines
US5155120A (en) 1991-01-14 1992-10-13 Pfizer Inc Method for treating congestive heart failure
WO1993006082A1 (en) 1991-09-13 1993-04-01 Merck & Co., Inc. Process for the preparation of 4-substituted-1,4-dihydropyridines
US5389654A (en) 1992-11-26 1995-02-14 Lek, Tovarna, Farmacevtskih In Kemicnih . . . 3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate
HU221810B1 (hu) 1997-08-12 2003-01-28 EGIS Gyógyszergyár Rt. Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
ZA9810320B (en) 1997-11-14 2000-05-11 Gea Farmaceutisk Fabrik As Process for the preparation of 1,4-dihydropyridines and novel compounds of use for such purpose.
ZA9810319B (en) * 1997-11-14 2000-05-11 Gea Farmaceutisk Fabrik As Process for the preparation of acetal derivatives of 1,4-dihydropyridines, novel acetal derivatives and the use of the acetal derivatives for the preparation of other 1,4-dihydropyridines.
PL189666B1 (pl) * 1998-04-09 2005-09-30 Adamed Sp Z Oo Sposób otrzymywania benzenosulfonianu amlodypiny
GB9812413D0 (en) 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
ES2151850B1 (es) 1998-10-26 2001-08-16 Esteve Quimica Sa Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente.
GB9827431D0 (en) 1998-12-11 1999-02-03 Smithkline Beecham Plc Novel compound
GB9827387D0 (en) 1998-12-11 1999-02-03 Smithkline Beecham Plc Novel process
CA2433288C (en) * 2000-12-29 2006-06-13 Pfizer Limited Process for making amlodipine maleate
CA2433193C (en) * 2000-12-29 2006-01-31 Pfizer Limited Amide derivative of amlodipine
ES2254495T4 (es) * 2000-12-29 2007-06-16 Pfizer Limited Hemimaleato de amlodipina.
WO2002053538A1 (en) * 2000-12-29 2002-07-11 Pfizer Limited Amlodipine fumarate
EP1309558A1 (en) * 2000-12-29 2003-05-14 Synthon Licensing, Ltd. Aspartate derivative of amlodipine as calcium channel antagonist

Also Published As

Publication number Publication date
FI6788U1 (fi) 2005-09-14
DK200300344U4 (da) 2005-09-09
DK200300344U1 (da) 2003-12-12
SI1309555T1 (sl) 2005-12-31
EP1309555B1 (en) 2005-07-27
NZ526506A (en) 2004-11-26
HRP20030526A2 (en) 2005-06-30
PT1309555E (pt) 2005-10-31
DE20115704U1 (de) 2002-02-14
AT7109U2 (de) 2004-10-25
ATE300520T1 (de) 2005-08-15
CN1272319C (zh) 2006-08-30
US20020086888A1 (en) 2002-07-04
FIU20030476U0 (fi) 2003-12-17
DK200300345U3 (da) 2004-03-12
BE1014452A6 (nl) 2003-10-07
AT7110U2 (de) 2004-10-25
DK1309555T3 (da) 2005-10-24
MA25984A1 (fr) 2003-12-31
HK1055965A1 (en) 2004-01-30
AP2003002820A0 (en) 2003-06-30
IL156692A0 (en) 2004-01-04
ES2243553T3 (es) 2005-12-01
CN1505614A (zh) 2004-06-16
NO20032518L (no) 2003-06-26
BR0116557A (pt) 2003-10-28
CA2433288C (en) 2006-06-13
DE60112305T2 (de) 2006-05-24
WO2002053542A1 (en) 2002-07-11
MXPA03005885A (es) 2005-04-19
EP1309555A1 (en) 2003-05-14
PL362660A1 (en) 2004-11-02
CA2433288A1 (en) 2002-07-11
AT7110U3 (de) 2005-05-25
AT7109U3 (de) 2005-05-25
AT7110U9 (de) 2004-11-25
US20030199559A1 (en) 2003-10-23
NO20032518D0 (no) 2003-06-04
RS53403A (xx) 2006-10-27
US6600047B2 (en) 2003-07-29
IS6834A (is) 2003-05-30
DE60112305D1 (de) 2005-09-01

Similar Documents

Publication Publication Date Title
HK1064671A1 (en) Process for making amlodipine maleate, the amlodipine maleate prepared, the pharmaceutical composition and the use thereof
AU6275601A (en) Stable polymeric micelle-type drug composition and method for the preparation thereof
HUP0303835A3 (en) Anti-allergic piperidine compounds, their use and pharmaceutical compositions containing them
DZ3313A1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
HUP0301069A3 (en) Novel biarylcarboxamides, process for their preparation, pharmaceutical compositions containing them and their use
IL156691A0 (en) Pharmaceutical compositions comprising amlodipine maleate
HUP0301187A3 (en) Novel benzyl-piperidine-derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0203836A3 (en) 1,3-disubstituted pyrrololidines as alpha-2-adrenoceptor antagonists, process for their preparation and pharmaceutical compositions containing them and their use
IL156662A0 (en) Oxazolidinone derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
IL151496A0 (en) Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
IL154096A0 (en) Aporphine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
IL154240A0 (en) 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
HUP0302515A3 (en) Sulfanidothienopyrimidines, process for their preparation and pharmaceutical compositions containing them
HUP0204394A3 (en) Tetrahydropyridines, process for their preparation, pharmaceutical compositions containing them and use thereof
HUP0302429A3 (en) 4-amino-quinazolines, process for producing them, pharmaceutical compositions containing them and their use
HUP0100146A3 (en) 3-(1-hydroxy-pentylidene)-5-nitro-3h-benzofuran-2-one, process for its preparation and use thereof
IL154986A0 (en) Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
IL162497A0 (en) Benzhydryl derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
GB2364640B (en) Anti-ulcer pharmaceutical composition and the preparation thereof
IL152205A0 (en) A solid dispersion, pharmaceutical compositions containing the same and methods for the preparation thereof
AU2001260083A1 (en) New pharmaceutical composition and the process for its preparation
HUP0303688A3 (en) Propanolaminotetralines, preparation thereof and pharmaceutical compositions containing same
EP1338275A4 (en) Pharmaceutical composition, its use and method of making the same
HUP0204393A3 (en) Pluraflavins and derivatives thereof, process for their preparation and use thereof

Legal Events

Date Code Title Description
CORR Corrigendum

Free format text: CORRECTED DATA OF SECTION 20 TO JOURNAL OF 20050204: (71) PFIZER LIMITED, 261 RAMSGATE ROAD, SANDWICH, KENT CT13 9NJ, UNITED KINGDOM ??????, ??/????

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100815